Ameriprise’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Sell |
65,933
-745
| -1% | -$15.3K | ﹤0.01% | 3122 |
|
|
2025
Q1 | $1.36M | Sell |
66,678
-5,154
| -7% | -$105K | ﹤0.01% | 3060 |
|
|
2024
Q4 | $1.63M | Buy |
71,832
+13,721
| +24% | +$311K | ﹤0.01% | 3012 |
|
|
2024
Q3 | $1.43M | Sell |
58,111
-18,903
| -25% | -$465K | ﹤0.01% | 3058 |
|
|
2024
Q2 | $1.78M | Sell |
77,014
-3,646
| -5% | -$84.3K | ﹤0.01% | 2917 |
|
|
2024
Q1 | $1.94M | Sell |
80,660
-19,164
| -19% | -$461K | ﹤0.01% | 2886 |
|
|
2023
Q4 | $2.3M | Buy |
99,824
+1,023
| +1% | +$23.5K | ﹤0.01% | 2802 |
|
|
2023
Q3 | $2.01M | Buy |
98,801
+8,644
| +10% | +$176K | ﹤0.01% | 2813 |
|
|
2023
Q2 | $2.11M | Buy |
90,157
+15,884
| +21% | +$371K | ﹤0.01% | 2845 |
|
|
2023
Q1 | $1.73M | Buy |
74,273
+34,066
| +85% | +$791K | ﹤0.01% | 2907 |
|
|
2022
Q4 | $942K | Buy |
40,207
+1,871
| +5% | +$43.8K | ﹤0.01% | 3158 |
|
|
2022
Q3 | $1.01M | Buy |
38,336
+5,011
| +15% | +$132K | ﹤0.01% | 3106 |
|
|
2022
Q2 | $963K | Buy |
33,325
+17,310
| +108% | +$500K | ﹤0.01% | 3139 |
|
|
2022
Q1 | $552K | Sell |
16,015
-2,358
| -13% | -$81.3K | ﹤0.01% | 3446 |
|
|
2021
Q4 | $805K | Buy |
+18,373
| New | +$805K | ﹤0.01% | 3346 |
|